Eagle Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP EGRX

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/7/2024

11,087

Value ($000)

Weight

0.0%

2020 Q1 - 2024 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/7/2024	58	0.0%	11,087	3/31/2024
2023 Q4	2/14/2024	254	0.0%	48,596	12/31/2023
2023 Q3	11/14/2023	674	0.0%	42,740	9/30/2023
2023 Q2	8/11/2023	1,108	0.0%	57,006	6/30/2023
2023 Q1	5/16/2023	2,082	0.0%	73,400	3/31/2023
2022 Q4	2/14/2023	554	0.0%	18,951	12/31/2022
2022 Q3	11/14/2022	499	0.0%	18,904	9/30/2022
2022 Q1	5/16/2022	468	0.0%	9,451	3/31/2022
2021 Q4	2/14/2022	884	0.0%	17,366	12/31/2021
2021 Q3	11/15/2021	545	0.0%	9,769	9/30/2021
2021 Q2	8/11/2021	400	0.0%	9,355	6/30/2021
2021 Q1	5/17/2021	249	0.0%	5,957	3/31/2021
2020 Q3	11/16/2020	271	0.0%	6,372	9/30/2020
2020 Q1	5/15/2020	324	0.0%	7,045	3/31/2020